|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities- | |||||
| Amortization of identifiable intangible assets | |||||
| Depreciation expense | |||||
| Change in right-of-use assets | |||||
| Bad debt expense | |||||
| Deferred tax provision (benefit) | |||||
| Amortization of debt financing costs | |||||
| Gain on sale of assets | |||||
| Changes in the fair value of contingent earn-out obligations | |||||
| Stock-based compensation | |||||
| Changes in operating assets and liabilities, net of effects of acquisitions and divestitures- | |||||
| (Increase) decrease in- | |||||
| Receivables, net | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Costs and estimated earnings in excess of billings and unbilled accounts receivable | |||||
| Other noncurrent assets | |||||
| Increase (decrease) in- | |||||
| Accounts payable and other current liabilities | |||||
| Billings in excess of costs and estimated earnings and deferred revenue | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Purchases of property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Payments for investments | |||||
| Proceeds from investments | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from revolving credit facility | |||||
| Payments on revolving credit facility | |||||
| Proceeds from other debt | |||||
| Payments on other debt | |||||
| Debt financing costs | |||||
| Payments of dividends to stockholders | |||||
| Share repurchases | |||||
| Shares received in lieu of tax withholding | |||||
| Proceeds from exercise of options | |||||
| Deferred acquisition payments | |||||
| Payments for contingent consideration arrangements | |||||
| Net cash used in financing activities | |||||
| NET INCREASE IN CASH AND CASH EQUIVALENTS | |||||
| CASH AND CASH EQUIVALENTS, beginning of period | |||||
| CASH AND CASH EQUIVALENTS, end of period | |||||
Loading...